Yes. millonaries want see first good results before put his money in a new treatmentindeed it is a joke, no one wil pay 500k to be a lab mouse
Could you/anybody gimme a quick summary please? Third world internet ain't good
Forget about Tsuji, you won't be able to afford his treatment for at least 10-20 years. Maybe in 30 years with a bit of luck lol.Could you/anybody gimme a quick summary please? Third world internet ain't good
From where do you get that info? I'm afraid, you post the exact same sentence literally everywhere. There is no statement from them.Stemson wont be cheaper, unfortunatelly
Didn't you tell me that couldn't possibly be the reason he hasn't found an investor?Yeah his pricing is a joke, this isn't a realistic option to look forward to. He has it at 138k-184k at product maturity (10k+ patients). This is probably why he can't find a investor/partner. The market for this is pathetically low and it's obvious that he's going to have competitors trying to enter the market, severely undercut his prices, or even beat him to market.
The clinical trial pricing is actually hilarious. They're going to charge people 500-700k USD to be part of a clinical research trial that's never been done on humans before at scale.
Youngjet is a motherfucking liar!! He Said Tsuji will Start human trials in 2020.Yoingjet is not a liar, he was right about the price range, remember my words, stemson will be as costly as tsuji
That was the plan. It's on Tsuji's Twitter that they had planned to start in 2020 if organ hadn't gone underYoungjet is a motherfucking liar!! He Said Tsuji will Start human trials in 2020.
I wish him a positive AIDS test
Tissuse said 50k. Stemson has alluded to a price in that range.why on stemson and tissuse? they didny say anything about the price so far
Out of curiousty, what makes you think Stemson won’t charge the average patient around that ball park ($200,000+)? From what I’ve seen they haven’t given an estimated price range on commercialization.Yeah his pricing is a joke, this isn't a realistic option to look forward to. He has it at 138k-184k at product maturity (10k+ patients). This is probably why he can't find a investor/partner. The market for this is pathetically low and it's obvious that he's going to have competitors trying to enter the market, severely undercut his prices, or even beat him to market.
The clinical trial pricing is actually hilarious. They're going to charge people 500-700k USD to be part of a clinical research trial that's never been done on humans before at scale.
Tbh I don’t expect Stemson to be nearly as expensive on commercial launch. Alexey mentioned about wanting to help out children with balding plus having that kind of a price range wouldn’t be an intelligent market plan at all. Assuming that clinical trials for Riken go perfectly, I don’t see thousands of patients wanting to spend half a million on launch. $50K-70K on commercial launch does make sense to me, I’m also cautiously optimistic with both the science behind Stemson plus the solid funding from Allergan and Fortunis. I would expect commercial release somewhere between 2024-2026, especially with them being a lot more organized than Riken. Next year should tell us the future of Stemson.true, where did he get the price range from?
Dude, are you jan miezda, the real one, under an alt account?? Lolfirst of all the question is whether or working on humans or not....timeline at the moment i nonsense
That's obvious. I'm just stating what the timeline would look like if it were to work, including delays. They did mention that the pig trials have been successful in a Fortunis video on another thread, pig skin is similar to human skin which is why results from this trial will give a good indication on how it will most probably translate to humans. The mouse picture was a good starting point, as well as hair cycles having been established and Alexey did state that the "fundamental problems have been solved, it's more technical".first of all the question is whether or working on humans or not....timeline at the moment i nonsense